Slingshot members are tracking this event:
Advaxis Combination Trial with Merck Completes First Two Dose-Escalation Cohorts
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Apr 05, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Keynote-046, Keytruda, Lm Immunotherapy, Pembrolizumab, Adxs31-142, Anti-pd-1